Literature DB >> 15181055

Menopause transition: Annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause.

Britt-Marie Landgren1, Aila Collins, Giorgy Csemiczky, Henry G Burger, Lyrissa Baksheev, David M Robertson.   

Abstract

To examine the hormonal characteristics of menstrual cycles in healthy women approaching menopause, serum hormone profiles were investigated annually in this longitudinal study of 13 healthy women between 4 and 9 yr before menopause and the year of the menopause. Serum FSH, LH, estradiol, progesterone, total inhibin, inhibins A and B, and prolactin were determined in blood samples collected annually three times weekly for 4 wk beginning with the onset of menses. Menstrual bleeding diaries covering this 4- to 9-yr period were also collected allowing the prospective identification of the final menstrual period. A change in serum hormone patterns was observed in cycles approaching menopause, exemplified by an increasing number of cycles of prolonged length with a prolonged follicular phase resulting in a failure to detect a luteal phase rise in serum progesterone within the 4-wk collection period. These prolonged cycles (designated B cycles based on a previous work) were analyzed separately and compared with the remaining ovulatory (D) cycles. No B cycles were identified in any women earlier than 27 cycles from menopause. The proportion of B cycles increased as menopause approached, reaching 62% in the last 10 cycles. The proportion of D cycles decreased accordingly. The B cycles during the initial 4-wk collection period were characterized by elevated FSH, LH, FSH/inhibin A and FSH/inhibin B ratios, and longer duration, although cycle length/subject was not significantly different presumably due to the small number of B cycles. The D cycles showed no changes in hormonal profiles over the 4- to 9-yr time period. These data indicate that there is a time-related change in the character of menstrual cycles as menopause approaches, with an increasing proportion of cycles observed with prolonged follicular phases that may either be delayed ovulatory cycles or anovulatory cycles. The increase in the proportion of B cycles with elevated early follicular phase FSH levels and low inhibin/FSH ratios toward menopause provides a basis for the apparent early increase in serum FSH and decrease in serum inhibins observed previously in studies of the menopause transition based on sampling confined to the follicular phase only. The data amplify and clarify current concepts of the endocrine basis of the menopause transition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181055     DOI: 10.1210/jc.2003-030824

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  Impact of cancer therapies on ovarian reserve.

Authors:  Clarisa R Gracia; Mary D Sammel; Ellen Freeman; Maureen Prewitt; Claire Carlson; Anushree Ray; Ashley Vance; Jill P Ginsberg
Journal:  Fertil Steril       Date:  2011-12-02       Impact factor: 7.329

Review 2.  Menstruation and the menopausal transition.

Authors:  Siobán D Harlow; Pangaja Paramsothy
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

Review 3.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

4.  Progesterone and ovulation across stages of the transition to menopause.

Authors:  Kathleen A O'Connor; Rebecca Ferrell; Eleanor Brindle; Benjamin Trumble; Jane Shofer; Darryl J Holman; Maxine Weinstein
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

5.  Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study.

Authors:  M Farahmand; F Ramezani Tehrani; M Bahri Khomami; M Noroozzadeh; F Azizi
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

6.  Characterizing physiological and symptomatic variation in menstrual cycles using self-tracked mobile-health data.

Authors:  Kathy Li; Iñigo Urteaga; Chris H Wiggins; Anna Druet; Amanda Shea; Virginia J Vitzthum; Noémie Elhadad
Journal:  NPJ Digit Med       Date:  2020-05-26

7.  An Integrated Quantitative Methodology to Longitudinally Characterize Complex Dynamic Processes Associated with Ovarian Aging and the Menopausal Transition.

Authors:  Huiyong Zheng; Maryfran Sowers; John F Randolph; Siobán D Harlow
Journal:  J Syst Cybern Inf       Date:  2011

8.  Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles.

Authors:  Lauren Johnson; Mary D Sammel; Allison Schanne; Lara Lechtenberg; Maureen Prewitt; Clarisa Gracia
Journal:  Fertil Steril       Date:  2016-09-22       Impact factor: 7.329

9.  Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women.

Authors:  Cornelia Charles; Julia Yuskavage; Olga Carlson; Majnu John; Arlene S Tagalicud; Marcello Maggio; Denis C Muller; Josephine Egan; Shehzad Basaria
Journal:  Menopause       Date:  2009 Mar-Apr       Impact factor: 2.953

10.  Factors related to declining luteal function in women during the menopausal transition.

Authors:  N Santoro; S L Crawford; W L Lasley; J L Luborsky; K A Matthews; D McConnell; J F Randolph; E B Gold; G A Greendale; S G Korenman; L Powell; M F Sowers; G Weiss
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.